Loading clinical trials...
Loading clinical trials...
Sildenafil is a phosphodiesterase inhibitor that can exert a nitric oxide-mediated vasodilation effect, so it's considered one of the preferred agents especially in hypoxia induced pulmonary hypertens...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ain Shams University
NCT07333183 · Pulmonary Hypertension, Interstitial Lung Disease (ILD), and more
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07537517 · Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension (PH), and more
NCT06770023 · Lung Transplant, Pulmonary Hypertension
NCT03854071 · Heart Failure, Pulmonary Hypertension, and more
Ain Shams University Hospital
Cairo, Abbasia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions